Charlotte presented her poster with the title Angiopoietin-2/ITGB1 targeted therapy suppresses tumor cell invasion and the formation of metastasis in small cell lung cancer at the Study Advisory Board MSSO Meeting which took place in the Center for Molecular Medicine Cologne.
Today Tabea has her first day in the lab. She will investigate novel therapeutic strategies for squamous cell lung carcinomas (SQLC). LIN28B expression marks a clinically relevant subgroup of patients which may benefit from anti-angiogenic therapy and immune checkpoint blockade. Welcome Tabea!
After a long break due to the COVID-19 pandemic, the annual congress of the DGHO (Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie) will take place in Berlin. Lydia is excited to talk about metastatic track and present our team's data on metastasis of small cell lung cancer in the session Metastasis as an invited speaker.
Today Charlotte had her first day in the lab. She will unravel mechanisms of invasion and metastasis in small cell lung cancer (SCLC). Welcome Charlotte!